ATE297392T1 - Substituierte imidazole, die sich für die behandlung entzündlicher krankheiten eignen - Google Patents

Substituierte imidazole, die sich für die behandlung entzündlicher krankheiten eignen

Info

Publication number
ATE297392T1
ATE297392T1 AT01987750T AT01987750T ATE297392T1 AT E297392 T1 ATE297392 T1 AT E297392T1 AT 01987750 T AT01987750 T AT 01987750T AT 01987750 T AT01987750 T AT 01987750T AT E297392 T1 ATE297392 T1 AT E297392T1
Authority
AT
Austria
Prior art keywords
treatment
substituted imidazoles
inflammatory diseases
imidazoles suitable
inflammatory cytokines
Prior art date
Application number
AT01987750T
Other languages
English (en)
Inventor
Scott Beers
Michael P Wachter
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE297392T1 publication Critical patent/ATE297392T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01987750T 2000-10-18 2001-10-17 Substituierte imidazole, die sich für die behandlung entzündlicher krankheiten eignen ATE297392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24125600P 2000-10-18 2000-10-18
PCT/US2001/032436 WO2002032894A1 (en) 2000-10-18 2001-10-17 Substituted imidazoles useful in the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
ATE297392T1 true ATE297392T1 (de) 2005-06-15

Family

ID=22909922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01987750T ATE297392T1 (de) 2000-10-18 2001-10-17 Substituierte imidazole, die sich für die behandlung entzündlicher krankheiten eignen

Country Status (8)

Country Link
US (1) US7041686B2 (de)
EP (1) EP1337526B1 (de)
JP (1) JP2004511554A (de)
AT (1) ATE297392T1 (de)
AU (1) AU2002224402A1 (de)
CA (1) CA2426337A1 (de)
DE (1) DE60111417T2 (de)
WO (1) WO2002032894A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
UA80295C2 (en) 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830063B2 (ja) * 1986-11-18 1996-03-27 富山化学工業株式会社 新規なイミダゾ−ル誘導体およびその塩
MX9300141A (es) 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
US5965583A (en) * 1997-04-24 1999-10-12 Ortho-Mcneil Pharmaceutical, Inc. Substituted imidazoles useful in the treatment of inflammatory disease
AU8757098A (en) 1997-06-30 1999-02-10 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
WO2000032598A1 (en) * 1998-12-04 2000-06-08 Structural Bioinformatics Inc. Methods and compositions for treating inflammatory diseases utilizing inhibitors of tumor necrosis factor activity

Also Published As

Publication number Publication date
JP2004511554A (ja) 2004-04-15
WO2002032894A1 (en) 2002-04-25
DE60111417D1 (de) 2005-07-14
EP1337526B1 (de) 2005-06-08
US7041686B2 (en) 2006-05-09
US20040214816A1 (en) 2004-10-28
AU2002224402A1 (en) 2002-04-29
EP1337526A1 (de) 2003-08-27
DE60111417T2 (de) 2006-03-16
CA2426337A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
CY1113654T1 (el) Αρυλ ουριες ως αναστολεις κινασων
TW200621779A (en) Process for the manufacture of dihydropteridinones
ATE386030T1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl- harnstoffverbindungen zur behandlung von zytokinvermittelten erkrankungen
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
BR9808998A (pt) Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
CY1109055T1 (el) 11-((4r,6r)-4,5,6-τριϋδροξυ-3-(r)-υδροξυ-εξυλοκαρβαμοϋλο)-ενδεκαϊνικο οξυ
TW200508225A (en) Cytokine inhibitors
EA200501399A1 (ru) Производные бензопирана, которые могут использоваться при лечении воспалительных заболеваний
TW200602313A (en) Anti-cytokine heterocyclic compounds
MXPA04004301A (es) Bencimidazoles sustituidos utiles como inhibidores de la proteina cinasa.
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
PL379543A1 (pl) Wytwarzanie pochodnych 1,3-difenyloprop-2-en-1-onu
NO20073839L (no) Kinolinderivat, fremgangsmate for fremstilling og anvendelse av dette, og legemiddel inneholdende dette
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
ATE329909T1 (de) 1,2,3-triazolamid-derivate als cytokininhibitoren
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
DE60318320D1 (de) Benzimidazolone und ihre verwendung als cytokininhibitoren
DE60111417D1 (de) Substituierte imidazole, die sich für die behandlung entzündlicher krankheiten eignen
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
GEP20074089B (en) Triazole compounds useful in therapy
UY28145A1 (es) Nuevos compuestos farmaceuticos
ATE320433T1 (de) 2-thia-dibenzoazulene als inhibitoren der produktion von tumornekrosefaktor und zwischenprodukte für deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties